Cannara Biotech, Inc. · TSX:LOVE

Cannara Biotech — Q3 2023 Earnings Presentation

44 slides from Cannara Biotech's earnings presentation, Aug 3, 2023

  1. Slide 1: Premium-Grade Cannabis at Scale

    TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB0 PREMIUM-GRADE CANNABIS AT SCALE INVESTOR DECK Q3 FISCAL 2023 (AS OF May 31, 2023)

  2. Slide 2: General Disclaimer

    GENERAL DISCLAIMER This corporate presentation dated August 3, 2023 (the “Presentation”) has been prepared by management of Cannara Biotech Inc. (the “Company” or “Cannara”) and is based on public information. This Presentation does not constitute an offer to sell to any person, or a general offer t

  3. Slide 3: Forward-Looking Statement

    FORWARD-LOOKING STATEMENT This presentation contains “forward-looking information” within the meaning of Canadian securities legislation. This information and these statements, referred to herein as “forward-looking statements” are made as of the date of this presentation or as of the date of the ef

  4. Slide 4: Executive Summary

    EXECUTIVE SUMMARY si — , 4

  5. Slide 5: Corporate Overview

    CORPORATE OVERVIEW We are a vertically-integrated Canadian Licensed Producer of premium-grade cannabis and cannabis-derivative products • Canada’s fourth largest producer based on square footage. Two mega facilities based in Quebec, Canada spanning over 1.6 million square feet. • Currently serving c

  6. Slide 6: Corporate Milestones

    CORPORATE MILESTONES MARCH 2018 JANUARY 2019 FEBRUARY 2020 FEBRUARY 2021 APRIL 2021 JUNE 2021 OCTOBER 2021 $ TSXV IDEA CAPITAL CULTIVATION QUEBEC RETAIL LAUNCH TSXV LISTING VALLEYFIELD OCS RETAIL March 2018, idea is Cannara raises over Launches 170,000 sq Retail debut of its 3 Successfully uplisted

  7. Slide 7: Key Investor Considerations

    KEY INVESTOR CONSIDERATIONS Well Capitalized, Profitable, Fast-Growing Business Strategic Brand Portfolio • Three flagship in-house brands. • Cannabis revenues generated of $15.9M in Q3 2023 and $39.3M • Brand partnership with Exotic Genetix. for the first nine months of 2023. • Brand strategy with

  8. Slide 8: Operations

    OPERATIONS

  9. Slide 9: Farnham Facility

    FARNHAM FACILITY FARNHAM, QUEBEC LEASED 150,000 sq. ft. 625,000 sq. ft. facility provides 170,000 sq. ft. of LEASED cannabis operation. 294,000 sq. ft. PHASE 1 Fully automated with biomonitoring sensors in every 170,000 sq. ft. grow room to ensuring optimal conditions and an 3,500 Kg increased plant

  10. Slide 10: Valleyfield Facility

    VALLEYFIELD FACILITY SALABERRY-DE-VALLEYFIELD, QUEBEC Acquired in June 2021, the facility occupies 1,033,506 sq. ft. on 3,000,000 sq. ft. of land. One of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec. Provides ability to expand output capacity to 100,000kg of

  11. Slide 11: Valleyfield Facility Phase 1 and Phase 2

    VALLEYFIELD FACILITY SALABERRY-DE-VALLEYFIELD, QUEBEC PHASE 1 24 INDEPENDENT GROWING ZONES MEASURING 25,000 SQ.FT EACH 1,033,506 sq. ft. facility The completely automated facility is equipped with cutting edge technology including: : • 578,022 sq. ft. Main cultivation facility LED LIGHTING - FULLY B

  12. Slide 12: The Principals of Our Success

    THE PRINCIPALS OF OUR SUCCESS QUALITY ACCESSIBILITY BRAND CULTURE Premium “AAAA” cannabis Disruptive low pricing Grassroot brand culture Hang dried, slow cured Aligned with legacy market Transparency At scale Ideal for your everyday consumers Consumers become ambassadors Q3 FY 2023 | 12

  13. Slide 13: Premium-Grade Cannabis at Scale

    PREMIUM-GRADE CANNABIS AT SCALE Delivering a premium-quality product is at the heart of our ethos, resulting in high cannabinoid content and rich flavourful cannabis. Our cannabis employs methods used in the most sophisticated markets in the world such as California; cultivated from: RARE GENETICS H

  14. Slide 14: Exclusive US Brand Partnership in Canada

    EXCLUSIVE US BRAND PARTNERSHIP IN CANADA 50-Time US Award-Winning Seed Breeder EXOTIC GENETIX Exclusive Canadian Partnership with CANNARA Cannara holds an exclusive license to use, market, sell, and distribute products branded by Exotic Genetix throughout Canada, in addition to its three flagship br

  15. Slide 15: Accessibility

    ACCESSIBILITY

  16. Slide 16: Production Assets

    PRODUCTION ASSETS CANNARA’S ESTIMATED QUARTERLY PRODUCTION CAPACITY IN KG 18,000 kg 16,000 kg 14,000 kg 12,000 kg 10,000 kg 8,000 kg 6,000 kg 4,000 kg Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2026+ 2023 2023 2023 2024 2024 2024 2024 2025 2025 2025 2025 Q3 FY 2023 | 16

  17. Slide 17: Why Quebec

    WHY QUEBEC AVERAGE ELECTRICITY RATES BY PROVINCE IN CENTS PER KW HOUR 3.7¢/kWh CANNARA PREFERRED RATE Quebec has the lowest electricity rates in Canada (QC: 5.3¢/kWh vs. AB: 13.6¢/kWh). MB BC SK ON NS AB QC 5.3¢/kWh 5.9¢/kWh 7.7¢/kWh 8.9¢/kWh 9.8¢/kWh 11.4¢/kWh 13.6 ¢/kWh Quebec has the highest barr

  18. Slide 18: Cannara Pricing Strategy

    CANNARA PRICING STRATEGY CANNARA PRICING STRATEGY QUEBEC MARKET OVERVIEW PRICE - QUALITY MATRIX $19.90 /3.5G QUALITY AA OTHER BRANDS SKIMMING PREMIUM HIGH CANOPY BLK MARKET BEST VALUE TILRAY CARMEL ORGANIGRAM DECIBEL (QWEST) $25.60 /3.5G RUBICON (SIMPLY BARE) QUALITY AAAA CANNARA PRICE LOW COST PENE

  19. Slide 19: Q3 FY 2023

    Q3 FY 2023 | 20

  20. Slide 20: Our Unique Value Proposition

    OUR UNIQUE VALUE PROPOSITION Cannara is giving consumers what they want—premium quality cannabis at accessible, value-based pricing fit for frequent consumers and new entrants alike. The exceptional quality of our top-tier "AAAA" grade cannabis, along with our revolutionary low pricing, has led to a

  21. Slide 21: Portfolio of Brands

    PORTFOLIO OF BRANDS 98 ACTIVE SKUS AVAILABLE IN MARKET Our portfolio consists of three flagship brands – Tribal, Nugz and Orchid, all with distinctive identities and purpose, each filling a white space in Canada’s current cannabis market without compromising quality. All three brands offer premium-g

  22. Slide 22: Tribal brand

    Welcome to Tribal, Cannara’s house of genetics flagship brand. With a Canadian exclusive partnership with renowned US breeder Exotic Genetix, Tribal calls on consumers to enjoy the journey of new genetics across a variety of products, from dried flower and pre-rolls to full spectrum extracts and liv

  23. Slide 23: Nugz brand

    Nugz, your legacy dealer gone legal, has two staple flower offerings in addition to rotational offerings from Cannara’s grow houses and solventless concentrates. Flavour, potency, and premium quality bulk value are key attributes—when Nugz shows up its high-fives and good times all around! AVAILABLE

  24. Slide 24: Orchid CBD brand

    Orchid CBD is changing the perception of cannabis by being the better choice for consumers looking for premium, CBD-dominant and balanced cannabis products. When it comes to flower and pre-rolls, Orchid CBD offers CBD Runtz, a phenomenally well-rounded strain bred by Exotic Genetix. Our flower is ha

  25. Slide 25: Market and Growth Strategy

    MARKET and GROWTH STRATEGY

  26. Slide 26: Canadian Recreational Cannabis Market

    CANADIAN RECREATIONAL CANNABIS MARKET 2ND LARGEST LEGAL CANNABIS MARKET IN THE WORLD Monthly Retail Sales of Legal Cannabis Stores Legal Recreational Cannabis Market in Canada from October 2018 to December 2022 expected to reach $7.6B by 2026 (in million Canadian dollars) 10,000 Retail sales in mill

  27. Slide 27: 2023 Looking Ahead

    2023 LOOKING AHEAD 1. RESPOND TO MARKET DEMAND BY INCREASING PRODUCTION CAPACITIES In April of 2023, the 9 th growing zone was activated at the Valleyfield facility. Can produce up t o 30,500kg from 225,000 square foot of active canopy. 2. NEW PRODUCT OFFERING The company is focused on the innovatio

  28. Slide 28: 1. Increase Cannabis Supply

    1. INCREASE CANNABIS SUPPLY CANNABIS PRODUCTION & REVENUE GROWTH TRAJECTORY AS VALLEYFIELD PRODUCTION SCALES UP CANNABIS NET REVENUE IN $ MILLIONS AND KG SOLD CANNABIS PRODUCTION (TRIMMED BUDS) IN KG $16M $14.9 8000 kg 4582 KG 7,300 $14M 7000 kg $11.7 3,580 KG $12M $8.4 6000 kg $9.7 2,745 KG 2,415 K

  29. Slide 29: 2-3. New Product Offering

    2-3. NEW PRODUCT OFFERING 2 NEW GENETICS FOR FY 2023 2 NEW ACCEPTED GENETICS FY 2024 5 NEW LIVE RESIN FSE SKUs 4 NEW LIVE RESIN VAPE SKUs KIND AWARD BRAND OF THE YEAR KIND AWARD TERPENE PROFILE OF THE YEAR GELATO MINT CUBAN LINX TERPLE POWER SHERB GALACTIC RUNTZ TRIPLE BURGER INDICA SATIVA HYBRID IN

  30. Slide 30: 4. Increase Market Share

    4. INCREASE MARKET SHARE MARKET EXPANSION STRATEGY Cannara has created lean and profitable operations, proven to produce premium cannabis at scale and at competitive prices. With the ability to produce up-to 100,00 kg of premium cannabis at full scale, Cannara will expand its product offering across

  31. Slide 31: 5. Continued Positive EBITDA

    5. CONTINUED POSITIVE EBITDA With its 9th consecutive quarterly Adjusted EBITDA, Cannara expects to continue to report positive quarterly Adjusted EBITDA throughout FY 2023 and beyond QUARTERLY ADJUSTED EBITDA $5,000,000 $4,000,000 Valleyfield Facility start-up cost and redesign of 6 of 24 growing z

  32. Slide 32: Financials

    ra” canna ~”N oll < O Zz < Zz i

  33. Slide 33: Selected Financial Highlights

    SELECTED FINANCIAL HIGHLIGHTS Q3 2023 FINANCIAL OUTLOOK TRAILING TWELVE MONTH CUMULATIVE REVENUES $ 51 000 000 Cash $4M Current assets $45.7M Current debt $18.5M 1 Working capital $27.2M Total assets $135.3M $ 35 000 000 Net assets $74.9M Quarterly revenue $15.9M 2 Overall Gross margin 36% 2 $ 24 00

  34. Slide 34: Total Net Revenues by Quarter

    TOTAL NET REVENUES BY QUARTER TOTAL NET REVENUES ANALYSIS BY QUARTER IN $ MILLIONS -- TOTAL NET REVENUE GROSS MARGIN 1 $15.9 $14M $13 $12 $12M $10.3 $10.1 $10M $8M $7.4 $6.1 $6M $4,8 $5M $4.0 $4.0 $3.7 $4M $3M $2.6 $2M $1M 36% 37% 40% 39% 31% 38% $0M 4% Q2 Q3 Q4 Q1 Q2 Q3 2022 2022 2022 2023 2023 202

  35. Slide 35: Financial Ratios Comparison vs Peers

    FINANCIAL RATIOS COMPARISON VS PEERS SIGNIFICANT GROWTH RATE WITH STRONG MARGINS AND PROFITABLE RELATIVE TO PEERS Canopy Village Avant Tillray Aurora Organigram Cannara Decibel Rubicon Growth Farms Brands Market Cap in M 1866 326 244 155 90 55 55 51 28 Revenue (LTM) in M 627 403 215 161 51 65 89.7 2

  36. Slide 36: Q3 2023 Detailed Highlights

    Q3 2023 DETAILED HIGHLIGHTS FOOTNOTES 1 If all stock options outstanding were dilutive and all RSU outstanding w ere vested. 2 M arket capitalization is calculated based on number of outstanding common shares x share price. 3 Gross revenue included revenue from sale of goods, net of ex cise taxes, s

  37. Slide 37: Quarterly Detailed Highlights

    QUARTERLY DETAILED HIGHLIGHTS 1 Adjusted EBITDA and free cash flow are non-GAAP financial performance measures. A reconciliation of theses measures is presented in the MD&A av ailable on www.sedar.com. 2 Gross profit before fair v alue adjustments % is determined as Gross profit before fair v alue a

  38. Slide 38: Leadership Team

    LEADERSHIP TEAM

  39. Slide 39: Executive Leadership Team

    EXECUTIVE LEADERSHIP TEAM ZOHAR KRIVOROT NICHOLAS SOSIAK AVI KRIVOROT CHAIRMAN & CEO CFO CTO Zohar is an entrepreneur who has launched Nicholas is a CPA with an entrepreneurial spirit Av i has been in the information technology several successful businesses. He has founded, and passion for the Canna

  40. Slide 40: Executive Management Team

    EXECUTIVE MANAGEMENT TEAM ISSAM BEN MOUSSA NOEMI FOLLAIN ANTHONY MANOUK VP PRODUCTION & EXPERIMENTATION VP FINANCE GM & VP COMPLIANCE Issam is an engineer in Agronomy & Noemi is a Chartered Professional Anthony is an accomplished business biotechnology and has a PhD in plant Accountant and hav e 8 y

  41. Slide 41: Executive Management Team Continued

    EXECUTIVE MANAGEMENT TEAM CONTINUED BRIAN SHERMAN SCOTT CARROLL VP LEGAL AFFAIRS FRANCE LANDRY VP HUMAN RESOURCES VP MARKETING & SALES Brian brings industry experience having France joins the Cannara team with ov er Scott joins the Cannara team with serv ed as a senior member of the legal 17 years o

  42. Slide 42: Board of Directors

    BOARD OF DIRECTORS ZOHAR KRIVOROT MARY DUROCHER CHAIRMAN & CEO DIRECTOR Mary has been involved in the cannabis industry since the Zohar is an entrepreneur who has launched several infancy of the Marihuana for Medical Purposes successful businesses. He has founded, advised and Regulations introductio

  43. Slide 43: Positioned for National Success

    IN SUMMARY Well capitalized, profitable, fast-growing Operating with strong margins and with a business with an established history of execution. focus on positive EBITDA and positive net income, free cash flow and organic growth Offering customers the highest value through capital reinvestment. pro

  44. Slide 44: Thank You

    TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB THANK YOU www.cannara.ca investors.cannara.ca www.instagram.com/cannarabiotech www.facebook.com/cannarabiotech CANNARA HEADQUARTERS FARNHAM FACILITY VALLEYFIELD FACILITY 333 Decarie blv d, Suite 200 1144 Boulev ard Magenta E 1175 Boulev ard Gérard-Cadieux Saint-L

Cannara Biotech — Q3 2023 Earnings Presentation on 6ix